• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
  • View Item
  •   LillOA Home
  • Liste des unités
  • Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Virology and cell biology of the hepatitis ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1016/j.jhep.2014.06.031
PMID :
25443344
Title :
Virology and cell biology of the hepatitis C virus life cycle: an update.
Author(s) :
Dubuisson, Jean [Auteur correspondant] refId
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
François-Loïc, Cosset [Auteur correspondant]
Virus enveloppés, vecteurs et immunothérapie – Enveloped viruses, Vectors and Immuno-therapy [EVIR]
Journal title :
Journal of Hepatology
Journal of Hepatology Update: Hepatitis C
Pages :
S3-S13
Publisher :
Elsevier
Publication date :
2014-10-31
ISSN :
0168-8278
English keyword(s) :
Hepatitis C virus
Viral life cycle
Virus entry
Virus-host interactions
HAL domain(s) :
Sciences du Vivant [q-bio]
Sciences du Vivant [q-bio]/Microbiologie et Parasitologie/Virologie
Sciences du Vivant [q-bio]/Médecine humaine et pathologie
English abstract : [en]
Hepatitis C virus (HCV) is an important human pathogen that causes hepatitis, liver cirrhosis and hepatocellular carcinoma. It imposes a serious problem to public health in the world as the population of chronically infected ...
Show more >
Hepatitis C virus (HCV) is an important human pathogen that causes hepatitis, liver cirrhosis and hepatocellular carcinoma. It imposes a serious problem to public health in the world as the population of chronically infected HCV patients who are at risk of progressive liver disease is projected to increase significantly in the next decades. However, the arrival of new antiviral molecules is progressively changing the landscape of hepatitis C treatment. The search for new anti-HCV therapies has also been a driving force to better understand how HCV interacts with its host, and major progresses have been made on the various steps of the HCV life cycle. Here, we review the most recent advances in the fast growing knowledge on HCV life cycle and interaction with host factors and pathways.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Comment :
Affiliations ECOFECT
Collections :
  • Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
Source :
Harvested from HAL
Files
Thumbnail
  • https://hal.archives-ouvertes.fr/hal-01140479/document
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Thumbnail
  • https://hal.archives-ouvertes.fr/hal-01140479/document
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Thumbnail
  • https://hal.archives-ouvertes.fr/hal-01140479/document
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Thumbnail
  • https://doi.org/10.1016/j.jhep.2014.06.031
  • Open access
  • Access the document
Université de Lille

Mentions légales
Université de Lille © 2017